Gene · 429
Papers4,495
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
661 to 680 of 4,495
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Taking it up a notch: a promising immunotherapy against small cell lung cancer. | Transl Lung Cancer Res | 2023 | 37323167 | PubTator, text mining | PubMed |
| Identification of a methylation panel as an alternative triage to detect CIN3+ in hrHPV-positive self-samples from the population-based cervical cancer screening programme. | Clin Epigenetics | 2023 | 37322534 | PubTator, text mining | PubMed |
| Characterizing the targets of transcription regulators by aggregating ChIP-seq and perturbation expression data sets. | Genome Res | 2023 | 37308292 | PubTator, text mining | PubMed |
| Evaluation of dihydrotestosterone and dihydroprogesterone levels and gene expression of genes involved in neurosteroidogenesis in the SH-SY5Y Alzheimer disease cell model. | Front Neurosci | 2023 | 37304028 | PubTator, text mining | PubMed |
| Lung Cancer through Transcription Factors. | Int J Mol Sci | 2023 | 37298412 | PubTator, text mining | PubMed |
| The Genomic and Epigenomic Landscape of Double-Negative Metastatic Prostate Cancer. | Cancer Res | 2023 | 37289025 | PubTator, text mining | PubMed |
| Lipopolysaccharide increases bitter taste sensitivity via epigenetic changes in Tas2r gene clusters. | iScience | 2023 | 37283808 | PubTator, text mining | PubMed |
| Corrigendum: Hierarchical reactivation of transcription during mitosis-to-G1 transition by Brn2 and Ascl1 in neural stem cells. | Genes Dev | 2023 | 37277169 | PubTator, text mining | PubMed |
| Poly (β-amino Ester) Nanoparticles Modified with a Rabies Virus-derived peptide for the Delivery of ASCL1 Across a 3D In Vitro Model of the Blood Brain Barrier. | ACS Appl Nano Mater | 2023 | 37274933 | PubTator, text mining | PubMed |
| Pluripotent Stem Cell-derived Dopaminergic Neurons for Studying Developmental Neurotoxicity. | Stem Cell Rev Rep | 2023 | 37273171 | PubTator, text mining | PubMed |
| STAT1 is required to establish but not maintain interferon-γ-induced transcriptional memory. | EMBO J | 2023 | 37272165 | PubTator, text mining | PubMed |
| SOX9 Governs Gastric Mucous Neck Cell Identity and Is Required for Injury-Induced Metaplasia. | Cell Mol Gastroenterol Hepatol | 2023 | 37270061 | PubTator, text mining | PubMed |
| Single-Cell Evolutionary Analysis Reveals Drivers of Plasticity and Mediators of Chemoresistance in Small Cell Lung Cancer. | Mol Cancer Res | 2023 | 37256926 | PubTator, text mining | PubMed |
| Photobiomodulation therapy activates YAP and triggers proliferation and dedifferentiation of Müller glia in mammalian retina. | BMB Rep | 2023 | 37254570 | PubTator, text mining | PubMed |
| Dynamic transition of molecular subtypes in relapsed small cell lung cancer treated with multimodal therapy: A case report. | Thorac Cancer | 2023 | 37253435 | PubTator, text mining | PubMed |
| Understanding SCLC heterogeneity and plasticity in cancer metastasis and chemotherapy resistance. | Acta Biochim Biophys Sin (Shanghai) | 2023 | 37249335 | PubTator, text mining | PubMed |
| macroH2A2 antagonizes epigenetic programs of stemness in glioblastoma. | Nat Commun | 2023 | 37244935 | PubTator, text mining | PubMed |
| Gene Therapy Using Efficient Direct Lineage Reprogramming Technology for Neurological Diseases. | Nanomaterials (Basel) | 2023 | 37242096 | PubTator, text mining | PubMed |
| Deciphering the Molecular Mechanisms of Autonomic Nervous System Neuron Induction through Integrative Bioinformatics Analysis. | Int J Mol Sci | 2023 | 37240399 | PubTator, text mining | PubMed |
| Targeted Therapies in Small Cell Lung Cancer: From Old Failures to Novel Therapeutic Strategies. | Int J Mol Sci | 2023 | 37240229 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/429/papers?page=34